What is the difference between high-risk smoldering myeloma and high-risk myeloma?
In this week’s video, Dr. Brian G.M. Durie explains the meaning of the term “risk,” as it relates to myeloma.
The use of the word “risk” in myeloma staging can be confusing.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.